Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kaori Narahara"'
Autor:
Hidehisa Tasaka, Kyoko Inooka, Fumi Yabuta, Ayako Zenda, Etsuko Enomoto, Hironori Nakamura, Takanori Hishinuma, Kanehiko Hisamichi, Yukinaga Kishikawa, Hitomi Furudate, Naoto Nakagawa, Kaori Narahara, Junichi Goto, Yuriko Murai, Hitoshi Nakamura
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 32:747-753
Cases of intervention in pharmacotherapy by pharmacists in the ophthalmology ward were collected and analyzed and the drug information obtained by doing this was provided to ophthalmologists and nurses at a study meeting. This significantly changed t
Autor:
Takanori Hishinuma, Kaori Narahara, Hiroki Tsukamoto, Junichi Goto, Risa Tayama, Yoshihisa Tomioka, Naoto Suzuki
Publikováno v:
Prostaglandins & Other Lipid Mediators. 74:61-74
9-cis Retinoic acid (9cRA) is a promising lead compound to design the retinoid X receptor (RXR) ligands with the ability to simultaneously activate RXR heterodimers with the selectivity to their nuclear receptor partners. In this study, we investigat
Autor:
Nadia Moursi, Mervat M. El-Enany, Mohammed S.-E. Ahmed, Kaori Narahara, Masahiro Hiratsuka, Naomi Endo, Samar Ismail Hamdy, Michinao Mizugaki
Publikováno v:
British Journal of Clinical Pharmacology. 55:560-569
Aims The goal of this study was to determine the frequencies of important allelic variants in the TPMT, NAT2, GST, SULT1A1 and MDR-1 genes in the Egyptian population and compare them with the frequencies in other ethnic populations. Methods Genotypin
Autor:
Mervat M. El-Enany, Naomi Endo, Masahiro Hiratsuka, Nadia Moursi, Mohammed S.-E. Ahmed, Kaori Narahara, Michinao Mizugaki, Samar Ismail Hamdy
Publikováno v:
British Journal of Clinical Pharmacology. 55:321-324
Aims The goal of this study was to determine the frequencies of CYP1A2*1C, *1D, *1E and *1F variants in the Egyptian population and compare frequencies with other populations. Methods Genotyping was performed in a total of 212 unrelated Egyptian subj
Autor:
Masahiro Hiratsuka, Nadia Moursi, Samar Ismail Hamdy, Mohammed S.-E. Ahmed, Kaori Narahara, Michinao Mizugaki, Mervat M. El-Enany
Publikováno v:
British Journal of Clinical Pharmacology. 53:596-603
Aims The goal of this study was to determine the frequencies of important allelic variants of CYP2C9, CYP2C19, CYP2E1 and DPYD in the Egyptian population and compare them with the frequencies in other ethnic populations.
Autor:
Tomoko Inoue, Samar Ismail Hamdy, Kaori Narahara, Naomi Endo, Masahiro Hiratsuka, Yasuyuki Agatsuma, Michinao Mizugaki, Yoshihisa Tomioka, Masaki Matsuura, Yukinaga Kishikawa
Publikováno v:
Clinical Biochemistry. 35:35-40
Objectives: The routine detection of polymorphisms affecting drug sensitivity in patients before treatment is important in the identification of drug responders or nonresponders, and patients at increased risk of drug toxicity. Here, we present an as
Autor:
Naomi Endo, Tomoko Inoue, Michinao Mizugaki, Kaori Narahara, Masahiro Hiratsuka, Junichi Goto, Yukinaga Kishikawa, Samar Ismail Hamdy, Masaki Matsuura, Yoh Takekuma
Publikováno v:
Drug Metabolism and Pharmacokinetics. 17:357-362
To investigate the association between NAT2 genotypes and the incidence of isoniazid (INH)-induced adverse reactions, in the hope of identifying a pharmacogenetic approach that could be useful in the prediction and prevention of adverse reactions in
Autor:
Masahiro Hiratsuka, Samar Ismail Hamdy, Michinao Mizugaki, Yasuyuki Agatsuma, Yukinaga Kishikawa, Kaori Narahara, Yoshihisa Tomioka, Tomoko Inoue
Publikováno v:
Analytical Biochemistry. 289:300-303
Autor:
Samar Ismail, Hamdy, Masahiro, Hiratsuka, Kaori, Narahara, Mervat, El-Enany, Nadia, Moursi, Mohammed Salah-Eldin, Ahmed, Michinao, Mizugaki
Publikováno v:
British journal of clinical pharmacology. 53(6)
The goal of this study was to determine the frequencies of important allelic variants of CYP2C9, CYP2C19, CYP2E1 and DPYD in the Egyptian population and compare them with the frequencies in other ethnic populations.Genotyping of CYP2C9 (*2 and *3), C
Autor:
Naomi Endo, Masaki Matsuura, Yasuyuki Agatsuma, Tomoko Inoue, Kaori Narahara, Yoh Takekuma, Masahiro Hiratsuka, Yukinaga Kishikawa, Michinao Mizugaki, Samar Ismail Hamdy
Publikováno v:
European journal of clinical pharmacology. 58(6)
Objective. The goal of this study was to determine the frequencies of allelic variants of CYP2B6 and CYP3A5 in the Japanese population. Methods. Genotyping of CYP2B6(*2, *3, *4, *5, *6, and *7) and CYP3A5 (*2, *3, *4, *5, and *6) was carried out in 2